Remaining Challenges With Transcatheter Left Atrial Appendage Closure.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33012352.
- Also identified by DOI 10.1016/j.mayocp.2020.07.032 and PMC identifier 7528944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However, certain issues remain unresolved with the technology. Knowledge of these issues, their significance, and the current and future efforts to resolve them is key for proper informed decision making by physicians and patients.
Medical subject headings
- Atrial Appendage
- Atrial Fibrillation
- Cardiac Catheterization